- Investing Ideas
- /
- Swiss Potentially Undervalued Companies
Swiss Potentially Undervalued Companies
Results
379
0 new
Companies with a Value score of at least 3, ordered by Value score
379 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
LEHN | CHF 1,338.00 | -1.9% | -34.7% | CHF 1.5b | CHF 1,610.50 | PE30.7x | E18.4% | 3.7% | Tech | ||
MDLZ | US$61.00 | 0% | 0% | US$99.3b | US$64.76 | PE25.2x | E7.3% | 2.5% | Food, Beverage & Tobacco | ||
BARC | UK£1.71 | 0% | 0% | UK£33.0b | UK£2.01 | PB0.5x | E12.8% | 3.6% | Banks | ||
SUN | CHF 139.00 | 5.8% | 58.6% | CHF 4.7b | CHF 149.80 | PE19.5x | E11.1% | 2.7% | Capital Goods | ||
SDF | €20.88 | 0% | 0% | €2.0b | €24.27 | PE470.9x | E74.9% | 6.2% | Materials | ||
HYU | ₩56.70 | 0% | n/a | ₩62.3t | ₩76.79 | PE5.7x | E4.7% | 4.5% | Automobiles | ||
SREN | CHF 117.65 | 1.2% | 24.7% | CHF 34.2b | CHF 116.05 | PE11.4x | E5.4% | 4.9% | Insurance | ||
4MGN | US$31.61 | 0.9% | n/a | US$9.6b | US$36.81 | PE14.7x | E9.8% | n/a | Media | ||
NESNE | CHF 84.88 | 2.4% | -18.5% | CHF 218.1b | CHF 98.79 | PE19.5x | E5.8% | 3.5% | Food, Beverage & Tobacco | ||
GOOGL | US$1,200.00 | 0% | 0% | US$2.0t | US$1,497.10 | PE22.9x | E12.4% | 0.5% | Media | ||
NOVN | CHF 97.90 | -1.1% | 4.3% | CHF 198.2b | CHF 98.48 | PE23.3x | E9.4% | 3.1% | Pharmaceuticals & Biotech | ||
MBTN | CHF 1.59 | 2.8% | -99.4% | CHF 49.0m | CHF 6.03 | PB0.3x | E95.4% | n/a | Semiconductors | ||
SEGN | CHF 3.94 | -1.5% | -0.5% | CHF 177.5m | n/a | PE12.9x | n/a | 5.1% | Real Estate Management and Development | ||
GF | CHF 65.20 | 2.2% | 26.2% | CHF 5.3b | CHF 75.33 | PE25.6x | E22.5% | 2.0% | Capital Goods | ||
SQN | CHF 312.00 | 2.9% | 86.2% | CHF 4.6b | CHF 310.50 | PE18.1x | E12.6% | 1.4% | Diversified Financials | ||
QIA | US$50.36 | 0% | 0% | US$9.2b | US$61.37 | PE27x | E11.3% | n/a | Pharmaceuticals & Biotech | ||
935700 | US$68.48 | 0% | 10.5% | US$94.1b | US$82.84 | PE17.2x | E7.8% | 4.0% | Pharmaceuticals & Biotech | ||
912061 | US$238.02 | 0% | -2.2% | US$66.7b | US$282.96 | PE35.1x | E15.7% | 1.5% | Healthcare | ||
CONT | €144.60 | 0% | 0% | €11.8b | €184.15 | PE14.5x | E25.6% | 3.7% | Automobiles | ||
GALE | CHF 74.40 | 1.8% | 10.8% | CHF 3.7b | CHF 76.38 | PE21.8x | E4.9% | 3.0% | Healthcare | ||
SCMN | CHF 554.00 | 2.1% | 2.1% | CHF 28.7b | CHF 547.35 | PE16.9x | E-0.5% | 4.0% | Telecom | ||
SOON | CHF 299.80 | 0.9% | 39.3% | CHF 17.9b | CHF 287.53 | PE29.7x | E8.1% | 1.4% | Healthcare | ||
GXI | €75.60 | 0% | 0% | €3.3b | €102.30 | PE29x | E22.2% | 1.3% | Pharmaceuticals & Biotech | ||
HNR1 | €159.00 | 0% | 0% | €30.6b | €155.13 | PE15.1x | E8.5% | 2.8% | Insurance |